HCW Biologics is trading 6.4% down in pre-market at $3.21 after a sharp multi-session rally.
- Shares gained 17.41% on August 27 and 8.20% on August 28.
- No company-specific announcement dated August 31, 2026, has been identified to explain the pre-market decline.
- The latest company news was an August 25 research update; a recent S-1 resale registration may add overhang but is not confirmed as today’s catalyst.